WallStSmart
SMMT

Summit Therapeutics PLC

NASDAQ: SMMT · HEALTHCARE · BIOTECHNOLOGY

$21.46
+3.02% today

Updated 2026-04-30

Market cap
$16.50B
P/E ratio
P/S ratio
3,891.31x
EPS (TTM)
$-1.44
Dividend yield
52W range
$14 – $31
Volume
3.1M

Summit Therapeutics PLC (SMMT) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$25.87M$46.44M$69.38M$20.09M$18.38M$8.06M$6.12M$6.91M$10.94M$29.22M$35.71M$46.98M$76.38M$78.39M$75.46M$102.50M$113.37M$664.17M$202.95M$435.56M
Cash & equivalents
Current assets$23.57M$38.43M$25.30M$7.79M$10.60M$5.90M$4.15M$6.61M$5.11M$22.89M$29.70M$41.67M$50.80M$61.29M$62.11M$66.42M$97.31M$656.71M$189.71M$423.75M
Total liabilities$2.49M$6.33M$15.30M$7.77M$5.15M$2.24M$2.34M$2.41M$3.08M$6.67M$5.62M$51.35M$62.40M$22.59M$14.34M$23.05M$30.09M$537.51M$125.26M$46.81M
Current liabilities$1.26M$2.84M$6.60M$2.69M$1.76M$1.91M$2.02M$2.41M$3.08M$5.67M$4.57M$13.62M$26.81M$16.88M$9.90M$19.89M$25.62M$38.78M$20.41M$41.73M
Long-term debt$0.00$0.00$0.00$0.00$494.54M$100.00M
Shareholder equity
Retained earnings$-1.99M$-8.11M$-28.35M$-52.84M$-43.90M$-50.91M$-54.75M$-61.74M$-74.53M$-45.59M$-67.43M$-92.21M$-114.51M$-99.80M$-97.61M$-214.74M$-299.55M$-378.33M$-993.26M$-1.21B
Accounts receivable$0.00$1.27M$1.46M$1.05M$677380.00$492158.00$917692.00$917692.00$1.19M$1.19M$2.28M$4.74M$13.15M$7.95M$5.29M$10.19M$17.16M$6.12M$848000.00$557000.00
Inventory$48197.00$369353.00$670126.00$563979.00$-78033.00$486809.00$1.00$4.16M$563101.00$110557.00$0.00$0.00$2.00$-11.71M$7.16M$7.16M$2.44M
Goodwill$19.42M$19.42M$664000.00$1.00M$945666.00$829968.00$3.51M$2.38M$1.15M$2.03M$2.01M$1.80M$1.89M$1.86M